Short answer: Pyridoxine (vitamin B6) is a water-soluble essential B-vitamin existing in three interconverting vitamer forms (pyridoxine, pyridoxal, pyridoxamine) that all convert in vivo to the universal active coenzyme pyridoxal 5-phosphate (PLP) per Combs 2012 (Vitamins textbook). PLP is the required cofactor for more than 100 mammalian enzymes, almost all of which act on amino acids per Spinneker 2007 (Nutr Hosp). AAFCO 2024 Dog Food Nutrient Profiles set a minimum of 1.5 mg/kg dry matter for both growth and adult maintenance. PLP is essential for transamination, decarboxylation (neurotransmitter synthesis — serotonin, GABA, dopamine, norepinephrine), heme synthesis, glycogen breakdown, and niacin biosynthesis per Mahoney 1995 (J Nutr) canine work. Deficiency is rare on commercial AAFCO-compliant diets but produces microcytic anemia and peripheral neuropathy on experimental restriction. The KibbleIQ rubric treats AAFCO 2024-compliant complete-and-balanced formulations as meeting the pyridoxine minimum by definition.

The biochemistry — three vitamer forms converging on PLP

Per Combs 2012 (Vitamins textbook) and Spinneker 2007 (Nutr Hosp) vitamin B6 review, vitamin B6 is unusual among the B-vitamins in existing as three structurally distinct dietary forms that all converge on a single active coenzyme. The three forms are pyridoxine (a 2-methyl-3-hydroxy-5-hydroxymethyl-pyridine, most commonly added to vitamin premixes as the hydrochloride salt), pyridoxal (the aldehyde counterpart, most abundant in animal-source ingredients), and pyridoxamine (the amine counterpart, most abundant in plant-source ingredients). Each vitamer has a phosphorylated 5-prime counterpart. All six forms interconvert through phosphorylation-dephosphorylation by pyridoxal kinase and oxidation-reduction by pyridoxine 5-phosphate oxidase. The end-point of this metabolic flux is pyridoxal 5-phosphate (PLP), the universal active coenzyme.

The biochemical consequence is that dietary B6 from any of the three forms ultimately supports PLP-dependent enzymes. The practical consequence for pet food is that AAFCO ingredient definitions accept synthetic pyridoxine hydrochloride as the standard B6 source in vitamin premixes, with ingredient-sourced B6 (pyridoxal from organ meats, fish, poultry; pyridoxamine from grains and legumes) contributing the balance. Bioavailability differs modestly across forms and food matrices — pyridoxine hydrochloride in vitamin premixes has near-100 percent bioavailability, while plant-source pyridoxamine bound to glycosides has lower bioavailability per McCormick 2006 (Annu Rev Nutr).

AAFCO 2024 dog food minimum — 1.5 mg/kg dry matter

Per AAFCO 2024 Official Publication Dog Food Nutrient Profiles, the minimum pyridoxine requirement for both growth-and-reproduction and adult-maintenance dog foods is 1.5 mg/kg dry matter. The same minimum applies to all life stages because B6 requirement scales with protein intake and metabolic rate. AAFCO does not set a maximum upper limit for typical dietary inclusion because B6 is water-soluble and excess is excreted in urine; however, very high pyridoxine intake (orders of magnitude above the minimum, primarily from inappropriate over-supplementation) can produce sensory neuropathy in dogs and humans per Schaeffer 1989 (J Nutr) and the human literature reviewed in Spinneker 2007 — a feature unusual among water-soluble vitamins.

Per NRC 2006 Nutrient Requirements of Dogs and Cats, the requirement basis for the canine B6 minimum derives from studies establishing the dose at which PLP-dependent enzyme activities are restored, growth is normal, and hematology stays unremarkable across a range of body weight and protein-intake ranges. The NRC Recommended Allowance includes a safety factor for bioavailability differences across ingredient sources.

Functions — amino acid metabolism and neurotransmitter biosynthesis

Per Spinneker 2007 and Combs 2012, PLP is the required cofactor for more than 100 mammalian enzymes, with the great majority involved in amino acid metabolism. The major reaction classes are transamination (interconverting amino acids via aminotransferases like ALT and AST), decarboxylation (producing biogenic amines from amino acids), and racemization (rare in mammals, more common in microbes). Transamination is biochemically central because it allows the dog to interconvert non-essential amino acids and direct amino acid carbon skeletons into gluconeogenesis or the citric acid cycle for energy when dietary carbohydrate is low.

The decarboxylation reactions are clinically the most distinctive because they produce neurotransmitters: tryptophan decarboxylase produces serotonin (mood, GI motility), glutamate decarboxylase produces GABA (inhibitory CNS neurotransmitter), aromatic amino acid decarboxylase produces dopamine and norepinephrine, and histidine decarboxylase produces histamine. PLP is also required for heme synthesis (delta-aminolevulinic acid synthase, the rate-limiting step), glycogen breakdown (glycogen phosphorylase, where PLP is structurally essential rather than catalytic), and niacin biosynthesis from tryptophan via the kynurenine pathway. The kynurenine connection means B6 status affects niacin requirement — well-B6-replete dogs can synthesize some niacin from tryptophan, sparing dietary niacin.

Deficiency and excess — experimental versus clinical

Per Mahoney 1995 (J Nutr) canine B6 deficiency work and the broader NRC 2006 review, experimental B6 deficiency in dogs produces a recognizable syndrome: microcytic hypochromic anemia (from impaired heme synthesis), peripheral neuropathy (from impaired neurotransmitter synthesis), seizures in severe deficiency, dermatitis, and growth failure in puppies. Clinical B6 deficiency in modern small-animal practice is rare in dogs on commercial AAFCO-compliant diets but has been described in home-formulated diets without B-vitamin supplementation and in dogs on long-term isoniazid therapy (isoniazid antagonizes PLP).

Per Schaeffer 1989 (J Nutr) and Spinneker 2007, excess pyridoxine can paradoxically produce sensory neuropathy at intakes orders of magnitude above the AAFCO minimum — an unusual property among water-soluble vitamins. The mechanism is thought to involve direct neurotoxicity from very high pyridoxal in dorsal root ganglia. This makes B6 the one water-soluble B-vitamin where over-supplementation through whim-based home-additions to AAFCO-complete diets is a (rare) practical concern. The AAFCO-compliant pet food itself is not the risk; isolated B6 supplements added on top of a complete diet are.

How KibbleIQ scores pyridoxine adequacy

The KibbleIQ Dry Kibble Rubric treats AAFCO 2024-compliant complete-and-balanced formulations as meeting the pyridoxine 1.5 mg/kg DM minimum by definition. The rubric does not separately reward higher-than-minimum B6 because there is no evidence of incremental clinical benefit at higher inclusion in healthy dogs and modest excess offers no functional benefit (excess is excreted, very large excess is potentially neurotoxic per Schaeffer 1989). The rubric does penalize complete-and-balanced labeling failures per F1 of the docs/CONTENT_TEMPLATE.md taxonomy.

To check whether your dog’s food carries an AAFCO 2024-compliant complete-and-balanced statement, paste the ingredient list and packaging text into the KibbleIQ analyzer. For peer B-vitamin context, see our thiamine (B1) explainer, riboflavin (B2) explainer, niacin (B3) explainer, cobalamin (B12) explainer, and choline explainer. For broader fortification context, see our AAFCO statement explainer and the KibbleIQ methodology page.